Pancreatic Adenocarcinoma Resectable
8 clinical trials · Condition
◉ Watch Pancreatic Adenocarcinoma Resectable
| Record | Firm | Date |
|---|---|---|
| A Pilot Study of IRE for Resectable Pancreatic Cancer (NCT03337997) | University of Saskatchewan | 2021-10-01 |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03908333) | Medical College of Wisconsin | 2019-05-01 |
| Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer (NCT03750669) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-10-20 |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) (NCT03410030) | HonorHealth Research Institute | 2017-12-15 |
| Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer (NCT01715142) | Jean-Luc Van Laethem | 2013-03-21 |
Track Pancreatic Adenocarcinoma Resectable automatically
Every clearance here is in the API, with alerts when new ones post.